Related Experiment Video
Updated: Feb 17, 2026

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
Published on: September 6, 2024
TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin
X F Zheng1, D Florentino, J Chen
1Howard Hughes Medical Institute Department of Chemistry, Harvard University Cambridge, Massachusetts 02138, USA.
Abstract:
The rapamycin-sensitive signaling pathway is required to transduce specific mitogenic signals to the cell cycle machinery responsible for G1 progression. Genetic studies in yeast identified two related genes on this pathway, TOR1 and TOR2, thought to encode novel phosphatidylinositol kinases. We now show that an intact kinase domain is required for the G1 cell cycle functions of both proteins, for the ability of a mutation in a neighboring FKBP12-rapamycin-binding domain of the TOR1 protein to inhibit the growth of yeast cells when overexpressed, and for the essential function of the TOR2 protein. The G1 function of both TOR proteins is sensitive to rapamycin, but the essential function of TOR2 is not. Thus, FKBP12-rapamycin does not appear to inhibit the kinase activity of TOR proteins in a general way; instead, it may interfere selectively with TOR protein binding to or phosphorylation of G1 effectors.
Insights
The rapamycin-sensitive pathway, involving TOR1 and TOR2 proteins, regulates cell cycle progression. Kinase activity is crucial for G1 function, with rapamycin selectively inhibiting this process.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The rapamycin-sensitive pathway is crucial for transmitting mitogenic signals to the cell cycle machinery, specifically for G1 phase progression.
- Genetic studies in yeast identified TOR1 and TOR2 as key genes in this pathway, hypothesized to be novel phosphatidylinositol kinases.
Purpose of the Study:
- To investigate the functional requirement of the kinase domain in TOR1 and TOR2 proteins for their roles in G1 cell cycle progression.
- To elucidate the mechanism by which FKBP12-rapamycin affects TOR protein function, particularly concerning G1 phase and essential cellular processes.
Main Methods:
- Genetic analysis of yeast strains with mutations in TOR1 and TOR2 genes.
- Assessment of cell cycle progression (G1) and cell growth under various conditions, including rapamycin treatment.
- Functional characterization of the kinase and FKBP12-rapamycin-binding domains of TOR proteins.
Main Results:
- An intact kinase domain is essential for the G1 cell cycle functions of both TOR1 and TOR2 proteins.
- Overexpression of a mutated TOR1 protein (affecting the FKBP12-rapamycin-binding domain) inhibited yeast cell growth.
- The essential function of TOR2 requires an intact kinase domain, but this function is not sensitive to rapamycin.
- While the G1 function of both TOR proteins is rapamycin-sensitive, the essential function of TOR2 is not.
Conclusions:
- The kinase activity of TOR proteins is indispensable for their G1 cell cycle functions.
- FKBP12-rapamycin does not broadly inhibit TOR kinase activity but likely interferes selectively with effector interactions or phosphorylation.
- This selective interference suggests a nuanced regulatory mechanism of TOR proteins in cell cycle control and essential cellular processes.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Tyrosine Kinases
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

